Profile
Luis G.
Vargas worked as a Medical Director at Aerie Pharmaceuticals, Inc. from 2019 to 2021 and at Visiogen, Inc. from 2003 to 2009.
Former positions of Luis G. Vargas
Companies | Position | End |
---|---|---|
AERIE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2021-03-31 |
Visiogen, Inc.
Visiogen, Inc. Medical SpecialtiesHealth Technology Visiogen, Inc. develops products for cataract and refractive patients. It offers synchrony dual-optic accommodating intraocular lens and pre-loaded injector, which provide distance, intermediate, and near vision to presbyopic cataract patients. The company was founded on March 19, 2001 and is headquartered in Abbott Park, IL. | Chief Tech/Sci/R&D Officer | 2009-01-09 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Visiogen, Inc.
Visiogen, Inc. Medical SpecialtiesHealth Technology Visiogen, Inc. develops products for cataract and refractive patients. It offers synchrony dual-optic accommodating intraocular lens and pre-loaded injector, which provide distance, intermediate, and near vision to presbyopic cataract patients. The company was founded on March 19, 2001 and is headquartered in Abbott Park, IL. | Health Technology |
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Luis G. Vargas